Background: Chronic Obstructive Pulmonary Disease (COPD) is a multi-systemic and progressive disease. However the determinants of its impact on health related quality of life are not well-studied or understood in Nigeria. Objectives: To assess the determinants of health related quality of life in COPD Methods: Patients with stable COPD were recruited consecutively from the outpatient clinics of a university hospital. Health Related Quality of Life (HRQL) was assessed using the St. George's Respiratory Questionnaire (SGRQ) and the Forced Expiratory Volume in one second (FEV1), Forced Vital Capacity (FVC) were measured by a vitalograph spirometer. Results: Fifty patients were recruited for this study (male= 60%). The mean (SD) age was 69 (9) years. The overall mean (SD) SGRQ scores was 45.9 (26.5), 50.6 (29.2), 29.7 (19.9), 38.8 (22.0) for the symptom, activity, impact and total scores respectively. After adjusting for age, sex and smoking, self-reported breathlessness independently predicted on average 25.2, 36.8, 13.65 and 22.9 points increase in SGRQ symptom, activity, impact and total scores respectively. Self-reported weight loss predicted 12.2 points increase in the impact subscale. Conclusions: Self-reported breathlessness and weight loss are independent predictors of low HRQL score in COPD.
Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a growing cause of morbidity and mortality. It is projected to become the third leading cause of death worldwide by 2030 1, 2 . Although significant progress has been made in the assessment and management of patients with COPD over the last four decades, the care of persons with this disease remains challenging because of it's progressive and multisystemic nature.
COPD is usually assessed using outcome measures like number of hospitalization, exacerbations, mortality and lung function parameters 3, 4 . However these measures do not provide a comprehensive assessment of the health status of the patients. There is growing evidence that shows that relying only on mortality and lung function measures for assessing effectiveness of treatments could be misleading in conditions like COPD that have notable non-respiratory systemic manifestations 5, 6 . As such, Health Related Quality of Life (HRQL) measures have achieve widespread acceptance because they provide a holistic assessment of the impact of the disease and benefits of treatments. Among these quality of life measures, the St Georges Respiratory Questionnaire (SGRQ) has been shown to be valid and specific for COPD 7, 8 . Quality of life (QoL) evaluation is relatively new in developing countries. It can influenced by various factors including socio-economic status and may vary between populations 9, 10 . We are unaware of any study in Nigeria that has assessed the quality of life of patients with COPD. The relation of QoL measures to traditional outcomes of COPD like lung function measures and the factors that predict them are not well understood. The use of quality of life instruments holds potential use in rural and suburban health facilities in developing countries where access to spirometry and other objective measures of lung function may be lacking. The availability of adapted QoL measures may provide substantial and complementary benefit for patients with COPD and their care providers. The aim of this study was to assess the relation of SGRQ scores to lung function especially forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and to determine the factors that predict its component and total scores.
Methods

Study design
It was a cross-sectional study carried out at the medical outpatient department of Obafemi Awolowo University Teaching Hospital (OAUTH), Ile-Ife. OAUTH is a tertiary hospital located in southwest Nigeria. . The SGRQ has been used extensively for assessing QoL in patients with COPD and several other chronic lung diseases [12] [13] [14] . It was developed by PW Jones of the St George's hospital medical school, London in 1991. It is sensitive, valid, reliable and responsive among patients with COPD. It contains 50 items with 76 weighted responses that cover three domains: symptoms -distress due to respiratory symptoms, activity -disturbances of physical activity and impact -overall impact on daily life and well-being. In addition to the domain scores, there is also a total score 7 . The SGRQ is scaled from zero to 100 (with zero representing the best health-related quality of life). This questionnaire which was forward and back translated in Yoruba language, was administered to each participant. However those unable to selfcomplete the questionnaire due to shaky hands, inability to read, or poor eye sight had the questionnaire read to them in the exact format in which they were set out without bias or undue emphasis and their responses were ticked as appropriate.
Study participants
Lung function parameters
Lung function test was performed using a standardized vitalograph bellows spirometer (Vitalograph Ltd, Buckingham, England). The following parameters were measured: forced expiratory volume in one second (FEV-1 ) and forced vital capacity (FVC). The reference values were derived using equations from a study by FemiPearse et al 15 . The parameters were assessed before and 20 minutes after the inhalation of 400ìg of Salbutamol using a metered dose inhaler (MDI) and a spacer device. The spacer was attached to the MDI and held in the mouth. After the patient had exhaled to functional residual capacity (FRC), the canister was activated. The patient inhaled slowly to total lung capacity (TLC) and held his/her breathe for ten (10) seconds 16 . This was done twice for every 200µg of Salbutamol released into the spacer device.
Exercise testing and dyspnoea rating Exercise performance was evaluated using the six minutes walk test (6-MWT) according to the American Thoracic Society guideline 17 . It is a simple, easy to administer and well tolerated functional walking test which is representative of the activities of daily living (ADL). This test was performed on a long, flat, straight and enclosed corridor. The walking course was 30m (100 -feet). The length of the corridor was marked every 3m and the turnaround points were also noted. A starting line, which marks the beginning and end of 60m lap, was marked on the floor using a brightly coloured marker. Patients appeared in their normal clothing on the day of the test with their shoes and walking aid, if any. The length walked was measured and the level of perceived breathlessness was measured both before and after the walk test using the visual analogue scale (VAS) The VAS is a dynamic scale used to assess a patient's perceived breathlessness. It has been shown to be a valid measure of dyspnoea on exertion 18 . The visual analogue scale consisted of a 20cm horizontal line. The word 'No Breathlessness' was written at the left end of the scale, 'Very Severe Breathlessness' was at the right end of the scale. It was scored from 0 to 100. Ratings were expressed as percents of the full VAS line length. Participants were asked to grade their shortness of breath with the scale before and after the six minutes walk test.
Data collection and Analysis
A proforma was used in recording sociodemographic data from each patient. Mean values and standard deviation (SD) was computed for all continuous parameters and frequencies and proportions for categorical variables. The correlation between quality of life scores, dyspnoea rating, six minutes walking distance and physiological parameters was assessed using Pearson's linear correlation coefficient.
The St Georges respiratory questionnaire was statistically analyzed using the excel-based scoring calculator from the developer. To identify the factors that influenced HRQL in these patients, a linear regression analysis was used. The model with the best fit was assessed using the changes in the Rsquared values adjusting for age, sex and smoking pack years. Ethical clearance was obtained from the hospital ethics committee and verbal informed consents were obtained from participants included in the study.
Results
Fifty patients were recruited for this study and sixty percent of the respondents were male. The mean age and standard deviation was 69 (9) years, body mass index (BMI) 22 (5) . The proportion of the stages of COPD were 10%, 34%, 34% and 22% for mild, moderate, severe and very severe stages of the disease respectively. The mean pre-bronchodilator FEV1 and FVC were 801ml and 1520ml while the post bronchodilator FEV1 and FVC were 817ml and 1570ml respectively. The overall mean (SD) SGRQ scores were 45.9 ± 26.5, 50.6 ± 29.2, 29.7 ± 19.9, 38.8 ± 22.0 for the symptom, activity, impact and total scales respectively (table 1). (20.4) in the symptom, activity, impact and total scales respectively. Women had worse SGRQ scores compared with men. As expected, previous heavy smokers had worse SGRQ score in the symptom subscale compared to never smokers (Data not shown). There was no current smoker in the sample. Table 2 shows the correlation coefficients between the SGRQ scores, lung function parameters, six minutes walking distance and VAS dyspnoea scores. The coefficients for FEV1 pre-bronchodilator were -0.19, -0.36, -0.26 and -0.31 for SGRQ symptoms, activity, impact and total scores respectively. The coefficients for pre-bronchodilator FVC were -0.13, -0.32, -0.18 and -0.24 respectively. The coefficients for pre-bronchodilator FEV1 and FVC were higher than the post bronchodilator values. The VAS scores post exercise showed correlation coefficients of 0.16, 0.36, 0.41 and 0.38 for SGRQ symptoms, activity, impact and total scores respectively. The activity subscale and total score demonstrated the best SGRQ correlation to FEV1, albeit weak, to lung function variables. Table 3 shows the results of the univariate analysis of the various study parameters. Notably, 
Discussion
The SGRQ designed by Jones PW has been used widely for measuring HRQL in persons with COPD especially in drug trials and other controlled interventional studies 19, 20 . Recently, a shorter version derived from the SGRQ, which is described as COPD Assessment Test (CAT) was developed by the same author 21 . However the use and relevance of these assessment tools in patients in low-income countries where access to respiratory care, spirometry and other modalities of managing COPD are largely inaccessible, is not well studied or understood. We found that patients with COPD had low selfperceived quality of life especially in the 'symptom' and 'activity' subscales of the SGRQ. HRQL showed a significant association with dyspnoea measures but showed weak and inverse relationship with spirometry. In addition, self reported dyspnoea and weight loss were the strongest independent predictors of HRQL. The quality of life scores of the present study generally indicate the patients had poor health status. In healthy individuals without symptoms of respiratory diseases, SGRQ scores are usually less than 15 units 22 and in clinical trials on patients with COPD, the minimum clinically important difference (MCID) for efficacy of a treatment is estimated to be 4 units 23, 24 . However, in cross sectional studies of diseased individuals, a relative approach is often used.in interpretation of SGRQ scores. Scores tending towards 100 are generally indicative of worse health status while scores tending towards 0 indicate a better quality of life score 7 . We found weak correlation between HRQL and Spirometry. The activity and total scales of the SGRQ showed the best correlation with pre-bronchodilator FEV1, but the coefficients were generally low ( Figure  1a-d) . A similar observation was found between SGRQ total score and post bronchodilator lung function values (Figure 2 ). Various correlation coefficients have been reported between HRQL and spirometry by several authors but the coefficients are usually weak 8, 25 . Spirometry objectively evaluates the lung's functional and ventilatory capacity however it often fails to evaluate the non-ventilatory manifestations of COPD like weight loss, mood changes including depression. Overall, it seems that spirometry and HRQL are important tools, which evaluate different aspects of the disease especially the impact on patients daily functioning. Spirometry evaluates the functional aspects of the airway calibre and informs on the progression of the disease, a measure described as a 'hard' measure by PW Jones 26 . However HRQL provides a holistic evaluation of the total impact of the disease especially in manifestations other than airway obstruction like weight loss, mood swings which explains its description as a 'soft' measure 26 . The combination of quality of life measures to the functional measures obtained from spirometry may provide a more thorough and comprehensive evaluation of patients with COPD.
The notable predictors of HRQL were selfreported breathlessness, weight loss, wheeze, sputum production and patient's subjective perception of In the symptom subscale, dyspnoea was the only significant explanatory variable independently accounting for 27% of the variance in the quality of life sub score. The classical symptoms of COPD like cough, sputum production and wheeze were not found to influence significantly on quality of life neither did functional variables like FEV1. This observation shows that breathlessness occupies an overriding influence on HRQL over other symptoms of the disease. In the activity subscale, breathlessness accounted for a greater proportion of the variance in the HRQL, representing 42% of the total variance in this subscale. This further shows that restriction in activity in COPD is primarily due to breathlessness. The variance in the impact subscale was also influenced independently by the perception of breathlessness, weight loss and dyspnoea score on the VAS post exercise. They accounted for 24% of the total variance in this subscale. The relatively low percentage in the accounted variance of the impact subscale model may be due to the fact that anxiety and depression were not measured in this study. Anxiety and depression have been shown to influence the impact score in COPD because they encompass the psychological and social dimension of the disease. It's been suggested that variables dependent on the psychological spheres exert a decisive influence on the way in which patients live with their disease and hence the HRQL 26 . Lastly, the multiple regression analysis performed using the SGRQ total score showed that adjusting for age, sex, FEV1 and smoking, the model which includes self reported breathlessness and weight loss account for 35% of the variance in the SGRQ total score. Weight loss has been reported as an indicator of outcomes in numerous studies on COPD 29, 30 . In our study, it accounted in the unadjusted model for 13% of the variance in the impact subscale and 11% of the total scores (data not shown). The aetiology of weight loss in COPD is possibly multi-factorial and factors implicated include increase workload of laboured breathing, under-nutrition due to breathlessness. The resultant effect is a reduction in muscle strength, endurance and participation in social activities and under-nourishment making COPD patients prone to recurrent infection, increase hospitalization and increased mortality from the disease 31 . This study has some limitations. It was a hospitalbased survey and as such, the participants included in the study may be skewed towards the very sick patients. Patients often do not access health care in low resource settings until their clinical condition becomes very dire because of the cost of care. This potentially limits the ability to generalise the results of this study to all COPD patients.
Conclusion
This study showed some important implications for the care of COPD in low-income settings. Spirometry remains a core investigative modality in the management of COPD however it should be complemented with measures of quality of life. In addition the presence of reported breathlessness indicates poor health status and local clinicians may use this variable as the primary indicator of a patient's self-perceived quality of life. A simple measure of breathlessness on a linear scale post exercise may also provide significant guide into the clinical state of a patient with COPD. This study also showed that SGRQ quality scores are weakly correlated with spirometry and it's core predictors are self-reported weight loss and breathlessness.
